Immunovant, Inc.

NASDAQ:IMVT

19.61 (USD) • At close March 11, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0001.50000000000000000.9260000000
Kosten van de omzet 000.080.0640.0580.3490.3430.3410.3330.3270.3230.3140.3130.3050.30.2410000.46300.3950.0680000
Brutowinst 00-0.081.436-0.058-0.349-0.343-0.341-0.333-0.327-0.323-0.314-0.313-0.305-0.3-0.2410000.4630-0.395-0.0680000
Brutowinstmarge 0000.9570000000000000000.50000000
Onderzoek- en ontwikkelingskosten 94.5297.27275.47366.05648.33847.95950.57551.83742.25237.73928.42931.98629.75621.36118.70518.61521.09111.97616.92214.1684.95310.33118.4767.977.6835.7454.335
Algemene en administratieve kosten 19.78218.47118.80814.82313.21513.84115.40212.42211.77511.87511.94615.24111.51516.28911.18110.30210.5498.9989.6646.3156.0884.1631.5850.9631.2010.4950.033
Verkoop- en marketingkosten 00-0.08-0.06400000000000000000000000
Verkoop-, algemene en administratieve kosten 19.78218.47118.72814.75913.21513.84115.40212.42211.77511.87511.94615.24111.51516.28911.18110.30210.5498.9989.6646.3156.0884.1631.5850.9631.2010.4950.033
Overige kosten 000.028-2.5871.0940.020.4640.356-1.7570.7930.3540.044-0.114-0.084-0.6260.68-0.5030.225-0.074-0.1270.2210.420.0920000
Bedrijfskosten 114.302115.74394.20180.81561.55361.865.97764.25954.02749.61440.37547.22741.27137.6529.88628.91731.6420.97426.58620.48311.0410.420.09208.8416.3464.368
Bedrijfsresultaat -114.302-115.743-94.281-80.879-51.526-58.208-73.948-64.313-44.027-49.614-40.375-47.266-41.385-37.65-29.886-28.917-31.64-20.974-26.586-20.483-11.041-0.42-0.092-0-8.884-6.24-4.368
Bedrijfsresultaat ratio 000-53.919000000000000000-22.1250000000
Totaal overige inkomsten en kosten netto 3.3326.7027.2085.79210.0273.5924.52913.836-8.8131.9470.3540.044-0.114-0.084-0.6260.68-0.5030.225-0.074-0.127-0.1550.6830.34200.043-0.106-0
Inkomen voor belasting -110.97-109.041-87.073-75.087-51.526-58.208-73.948-60.423-62.84-47.667-40.021-47.183-41.385-37.734-30.512-28.237-32.143-20.749-26.66-20.61-11.1960.2630.249-0-8.841-6.346-4.368
Inkomen voor belasting ratio 000-50.058000000000000000-22.2620000000
Belastingkosten 0.1520.0780.0770.232-0.1080.454-0.011-0.9920.3870.2610.352-0.012-0.28-0.031-0.041-0.079-0.3670.040.048-0.0590.10.1380.0660.0070.0080.004-0
Nettowinst -111.122-109.119-87.15-75.319-51.418-58.662-73.937-59.431-63.227-47.928-40.373-47.171-41.385-37.703-30.471-28.158-31.776-20.789-26.708-20.551-11.2960.1250.183-0-8.849-6.35-4.368
Nettowinstmarge 000-50.213000000000000000-22.1980000000
WPA (Winst Per Aandeel) -0.76-0.74-0.6-0.52-0.36-0.45-0.57-0.46-0.49-0.41-0.35-0.41-0.36-0.35-0.31-0.29-0.32-0.21-0.32-0.29-0.280.0440.0160-0.24-0.36-0.44
Verwaterde WPA -0.76-0.74-0.6-0.52-0.36-0.45-0.57-0.46-0.49-0.41-0.35-0.41-0.36-0.35-0.31-0.29-0.32-0.21-0.32-0.29-0.280.0090.064-0-0.24-0.36-0.44
EBITDA -114.203-115.654-94.201-80.815-61.495-61.744-65.924-64.205-53.978-49.568-40.331-47.188-41.238-37.429-29.86-28.28-31.621-20.96-26.576-20.604-10.82-0.42-0.092-0-8.88300
EBITDA ratio 000-53.877000000000000000-22.2550000000